148 related articles for article (PubMed ID: 12438259)
1. Characterization of a tissue-specific CDP/Cux isoform, p75, activated in breast tumor cells.
Goulet B; Watson P; Poirier M; Leduy L; Bérubé G; Meterissian S; Jolicoeur P; Nepveu A
Cancer Res; 2002 Nov; 62(22):6625-33. PubMed ID: 12438259
[TBL] [Abstract][Full Text] [Related]
2. CDP/Cux stimulates transcription from the DNA polymerase alpha gene promoter.
Truscott M; Raynal L; Premdas P; Goulet B; Leduy L; Bérubé G; Nepveu A
Mol Cell Biol; 2003 Apr; 23(8):3013-28. PubMed ID: 12665598
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of CDP/Cux p110 by cyclin A/Cdk2 and cyclin A/Cdk1.
Santaguida M; Nepveu A
J Biol Chem; 2005 Sep; 280(38):32712-21. PubMed ID: 16081423
[TBL] [Abstract][Full Text] [Related]
4. The p110 isoform of the CDP/Cux transcription factor accelerates entry into S phase.
Sansregret L; Goulet B; Harada R; Wilson B; Leduy L; Bertoglio J; Nepveu A
Mol Cell Biol; 2006 Mar; 26(6):2441-55. PubMed ID: 16508018
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of the CCAAT displacement protein (CDP)/Cux transcription factor by cyclin A-Cdk1 modulates its DNA binding activity in G(2).
Santaguida M; Ding Q; Bérubé G; Truscott M; Whyte P; Nepveu A
J Biol Chem; 2001 Dec; 276(49):45780-90. PubMed ID: 11584018
[TBL] [Abstract][Full Text] [Related]
6. A novel proteolytically processed CDP/Cux isoform of 90 kDa is generated by cathepsin L.
Goulet B; Truscott M; Nepveu A
Biol Chem; 2006 Sep; 387(9):1285-93. PubMed ID: 16972798
[TBL] [Abstract][Full Text] [Related]
7. Contribution of CDP/Cux, a transcription factor, to cell cycle progression.
Fei X; Qin Z; Liang Z
Acta Biochim Biophys Sin (Shanghai); 2007 Dec; 39(12):923-30. PubMed ID: 18064384
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mice expressing the p75 CCAAT-displacement protein/Cut homeobox isoform develop a myeloproliferative disease-like myeloid leukemia.
Cadieux C; Fournier S; Peterson AC; Bédard C; Bedell BJ; Nepveu A
Cancer Res; 2006 Oct; 66(19):9492-501. PubMed ID: 17018605
[TBL] [Abstract][Full Text] [Related]
9. The N-terminal region of the CCAAT displacement protein (CDP)/Cux transcription factor functions as an autoinhibitory domain that modulates DNA binding.
Truscott M; Raynal L; Wang Y; Bérubé G; Leduy L; Nepveu A
J Biol Chem; 2004 Nov; 279(48):49787-94. PubMed ID: 15377665
[TBL] [Abstract][Full Text] [Related]
10. Expression of N-terminally truncated isoforms of CDP/CUX is increased in human uterine leiomyomas.
Moon NS; Rong Zeng W; Premdas P; Santaguida M; Bérubé G; Nepveu A
Int J Cancer; 2002 Aug; 100(4):429-32. PubMed ID: 12115525
[TBL] [Abstract][Full Text] [Related]
11. Biochemical characterization of the mammalian Cux2 protein.
Gingras H; Cases O; Krasilnikova M; Bérubé G; Nepveu A
Gene; 2005 Jan; 344():273-85. PubMed ID: 15656993
[TBL] [Abstract][Full Text] [Related]
12. CASP, a novel, highly conserved alternative-splicing product of the CDP/cut/cux gene, lacks cut-repeat and homeo DNA-binding domains, and interacts with full-length CDP in vitro.
Lievens PM; Tufarelli C; Donady JJ; Stagg A; Neufeld EJ
Gene; 1997 Sep; 197(1-2):73-81. PubMed ID: 9332351
[TBL] [Abstract][Full Text] [Related]
13. Role of the multifunctional CDP/Cut/Cux homeodomain transcription factor in regulating differentiation, cell growth and development.
Nepveu A
Gene; 2001 May; 270(1-2):1-15. PubMed ID: 11403998
[TBL] [Abstract][Full Text] [Related]
14. Cux/CDP homeoprotein is a component of NF-muNR and represses the immunoglobulin heavy chain intronic enhancer by antagonizing the bright transcription activator.
Wang Z; Goldstein A; Zong RT; Lin D; Neufeld EJ; Scheuermann RH; Tucker PW
Mol Cell Biol; 1999 Jan; 19(1):284-95. PubMed ID: 9858552
[TBL] [Abstract][Full Text] [Related]
15. Cux/CDP homeodomain protein binds to an enhancer in the rat c-mos locus and represses its activity.
Higgy NA; Tarnasky HA; Valarché I; Nepveu A; van der Hoorn FA
Biochim Biophys Acta; 1997 Apr; 1351(3):313-24. PubMed ID: 9130595
[TBL] [Abstract][Full Text] [Related]
16. Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types.
Cadieux C; Kedinger V; Yao L; Vadnais C; Drossos M; Paquet M; Nepveu A
Cancer Res; 2009 Sep; 69(18):7188-97. PubMed ID: 19738070
[TBL] [Abstract][Full Text] [Related]
17. S phase-specific proteolytic cleavage is required to activate stable DNA binding by the CDP/Cut homeodomain protein.
Moon NS; Premdas P; Truscott M; Leduy L; Bérubé G; Nepveu A
Mol Cell Biol; 2001 Sep; 21(18):6332-45. PubMed ID: 11509674
[TBL] [Abstract][Full Text] [Related]
18. Genetic ablation of the CDP/Cux protein C terminus results in hair cycle defects and reduced male fertility.
Luong MX; van der Meijden CM; Xing D; Hesselton R; Monuki ES; Jones SN; Lian JB; Stein JL; Stein GS; Neufeld EJ; van Wijnen AJ
Mol Cell Biol; 2002 Mar; 22(5):1424-37. PubMed ID: 11839809
[TBL] [Abstract][Full Text] [Related]
19. Differentiation-induced cleavage of Cutl1/CDP generates a novel dominant-negative isoform that regulates mammary gene expression.
Maitra U; Seo J; Lozano MM; Dudley JP
Mol Cell Biol; 2006 Oct; 26(20):7466-78. PubMed ID: 17015474
[TBL] [Abstract][Full Text] [Related]
20. CDP/cut is the DNA-binding subunit of histone gene transcription factor HiNF-D: a mechanism for gene regulation at the G1/S phase cell cycle transition point independent of transcription factor E2F.
van Wijnen AJ; van Gurp MF; de Ridder MC; Tufarelli C; Last TJ; Birnbaum M; Vaughan PS; Giordano A; Krek W; Neufeld EJ; Stein JL; Stein GS
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11516-21. PubMed ID: 8876167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
